IRIS
RUSSO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.966
EU - Europa 2.608
AS - Asia 2.461
SA - Sud America 535
AF - Africa 465
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 10.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.844
SG - Singapore 1.149
RU - Federazione Russa 901
IT - Italia 700
CN - Cina 690
BR - Brasile 434
CI - Costa d'Avorio 264
IE - Irlanda 257
VN - Vietnam 215
DE - Germania 153
KR - Corea 142
FR - Francia 136
CA - Canada 90
FI - Finlandia 88
UA - Ucraina 74
NG - Nigeria 64
GB - Regno Unito 61
AT - Austria 49
NL - Olanda 48
SN - Senegal 42
TR - Turchia 41
BD - Bangladesh 37
AR - Argentina 36
KE - Kenya 33
IN - India 32
SE - Svezia 24
ZA - Sudafrica 24
AU - Australia 21
PL - Polonia 19
CZ - Repubblica Ceca 18
BE - Belgio 17
VE - Venezuela 17
JP - Giappone 16
PK - Pakistan 16
IQ - Iraq 15
MX - Messico 15
BJ - Benin 14
EC - Ecuador 13
CO - Colombia 12
ID - Indonesia 12
IR - Iran 12
UZ - Uzbekistan 11
ES - Italia 9
HK - Hong Kong 9
PT - Portogallo 9
CH - Svizzera 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
TW - Taiwan 7
BG - Bulgaria 5
CL - Cile 5
EG - Egitto 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LB - Libano 5
LT - Lituania 5
NP - Nepal 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
TN - Tunisia 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
HU - Ungheria 4
MA - Marocco 4
UY - Uruguay 4
ET - Etiopia 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
OM - Oman 3
PE - Perù 3
PH - Filippine 3
BO - Bolivia 2
BY - Bielorussia 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
MM - Myanmar 1
MT - Malta 1
Totale 10.061
Salva come PNG Salva come JPEG
Città #
Singapore 730
Dallas 685
Santa Clara 531
Chandler 435
Moscow 392
Abidjan 264
San Jose 253
Dublin 246
Ashburn 199
Chicago 182
Catania 175
Hefei 172
Seoul 142
Houston 114
Beijing 109
Boardman 105
Los Angeles 93
Lauterbourg 78
Ho Chi Minh City 70
Jacksonville 69
Civitanova Marche 63
Nuremberg 63
Cambridge 61
Lawrence 61
Andover 55
Council Bluffs 55
Hanoi 52
Helsinki 45
Dakar 42
New York 41
Nanjing 39
Lappeenranta 38
Des Moines 34
Rome 34
São Paulo 32
Vienna 31
Toronto 30
Abuja 28
Bremen 27
Lagos 26
Buffalo 24
Wilmington 23
Munich 22
Pozzallo 19
Amsterdam 18
Dong Ket 18
Falls Church 18
Kayseri 18
Montreal 18
Warsaw 18
Ottawa 17
Shanghai 17
Brno 16
Brussels 16
Columbus 16
Denver 16
Acireale 15
The Dalles 15
Cotonou 14
Nanchang 14
Rio de Janeiro 14
Atlanta 13
Messina 13
Saint Petersburg 13
Chennai 12
Johannesburg 12
Naples 12
Orem 12
Poplar 12
Tokyo 12
Belo Horizonte 11
Mascalucia 11
Melbourne 11
Nairobi 11
San Giovanni la Punta 11
Boston 10
Grafing 10
Palermo 10
Phoenix 10
Port Harcourt 10
Salvador 10
Seattle 10
Stockholm 10
Tianjin 10
Avola 9
Da Nang 9
Haiphong 9
Milan 9
Tehran 9
Brooklyn 8
Campinas 8
Cape Town 8
Hong Kong 8
Redondo Beach 8
San Mateo 8
Zhengzhou 8
Brasília 7
Changsha 7
Curitiba 7
Frankfurt am Main 7
Totale 6.652
Salva come PNG Salva come JPEG
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 320
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 190
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 189
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 187
Computational modelling in melanoma for novel drug discovery 177
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 174
Agent based modeling of the immune system: NetLogo, a promising framework 171
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 168
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 163
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 162
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 158
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 157
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 155
Boosting multiple sclerosis lesion segmentation through attention mechanism 154
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 152
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 150
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 146
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 144
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 142
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 139
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 139
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 137
In silico clinical trials: concepts and early adoptions 134
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 132
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 128
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 126
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 126
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 124
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 124
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 124
In silico design of recombinant multi-epitope vaccine against influenza A virus 123
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 120
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 117
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 116
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 114
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 113
Computational models to predict disease course and treatment response in multiple sclerosis 111
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 109
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 107
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 107
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation dataset 105
Credibility of In Silico Trial Technologies - A Theoretical Framing 105
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 103
Toward computational modelling on immune system function 102
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 101
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 101
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 99
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 99
PETAL: A Python tool for deep analysis of biological pathways 99
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 96
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 96
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 95
Introducing scale factor adjustments on agent-based simulations of the immune system 95
How can we accelerate COVID-19 vaccine discovery? 95
Generation of digital patients for the simulation of tuberculosis with UISS-TB 93
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 93
Modeling biology spanning different scales: An open challenge 92
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 91
The combination of artificial intelligence and systems biology for intelligent vaccine design 89
Text mining and word embedding for classification of decision making variables in breast cancer surgery 87
Optimization and analisys of vaccination schedules using simulated annealing and agent based models 86
Computational immunogenetics 85
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 85
Toward a Regulatory Pathway for the Use of in Silico Trials in The Ce Marking of Medical Devices 84
ODEs approaches in modeling fibrosis. Comment on "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Martine Ben Amar and Carlo Bianca 83
Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system 81
Computational modelling approaches to vaccinology 80
Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions 79
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers 78
Universal Immune System Simulator Analysis: The Impact of the Variable Approach Technique® on Enhancing Immune Defense Against infectious diseases 75
Modeling and Simulation of anakinra effects on severe COVID19 Patients 75
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern 73
Quality by design tools reducing the gap from bench to bedside for nanomedicine 73
Modeling PI3K/PDK1/Akt and MAPK Signaling Pathways using Continuous Petri Nets 70
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review 70
Machine Learning techniques application to predict the quality of life degree in breast cancer patients 70
Exploiting Stochastic Petri Net formalism to capture the Relapsing Remitting Multiple Sclerosis variability under Daclizumab administration 69
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform 69
Comment on “A decade of thermostatted kinetic theory models for complex active matter living systems” by Carlo Bianca 68
A Head-to-Head Evaluation of a Novel Universal Influenza Vaccine Against Current Formulation: Implications for Future Immunization Strategies 68
Generation of digital patients for the simulation of tuberculosis with UISS-TB 68
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility 68
UISS-GPU: Accelerated In-Silico Tuberculosis Vaccine Trials Using FLAME GPU 67
Novel computational strategies for the identification of new therapeutic targets in melanoma and thyroid cancer. 67
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim 65
Computational modeling approach to suggest possible therapeutic interventions in spinal muscular atrophy 63
Model Credibility 62
Evaluation of word embedding models to extract and predict surgical data in breast cancer 57
Model Development 55
Verification of an agent-based disease model of human Mycobacterium tuberculosis infection 55
Modeling, simulation and prediction of protein structures for the design of oncolytic viruses 53
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs 52
Toward computational modelling on immune system function 50
Breaking the Cycle: Advancements in Universal Influenza Vaccine Design 48
Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modeling 45
A Comparative Evaluation of Diffusion Based Networks for Multiple Sclerosis Lesion Segmentation 27
When Bioinformatics Meets Agent-Based Modeling: An Evolving Paradigm for Complex Biological Systems 21
Computational modeling of ATM signaling: a predictive framework for drug repurposing in ataxia-telangiectasia 18
Verify: A toolbox for deterministic verification of computational models 18
A computational framework for optimizing mRNA vaccine delivery via AI-guided nanoparticle design and in silico gene expression profiling 15
Totale 10.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 12 19 31
2021/2022479 48 57 4 13 84 9 62 26 35 20 14 107
2022/20231.111 72 81 23 163 98 173 7 178 217 14 39 46
2023/2024816 32 177 42 21 19 126 22 75 8 111 111 72
2024/20252.328 62 307 128 165 462 297 267 65 117 176 137 145
2025/20264.846 282 345 847 307 652 1.145 470 124 326 348 0 0
Totale 10.314